Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
PASO-DOBLE-studie: hiv-behandeling optimaliseren zonder in te leveren op effectiviteit
apr 2026